
William E Cohn MD
Adult Cardiac Surgery, Cardiopulmonary Transplantation, Minimally Invasive Cardiac Surgery, Cardiovascular Surgery
Professor, Transplant Surgery, Baylor College of Medicine
Join to View Full Profile
6770 Bertner AveSte C355Houston, TX 77030
Phone+1 832-355-3000
Dr. Cohn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Texas Heart Institute/Baylor College of MedicineFellowship, Thoracic Surgery - Independent, 1991 - 1993
- Baylor College of MedicineResidency, Surgery, 1986 - 1991
- Baylor College of MedicineClass of 1986
- Oberlin CollegeBS, Biology/Chemistry, Cum Laude, 1978 - 1982
Certifications & Licensure
- OH State Medical License 2024 - 2026
- TX State Medical License 1987 - 2026
- MA State Medical License 1993 - 2010
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Publications & Presentations
PubMed
- Centrally inserted central catheter placement using a novel, handheld, image-guided, robotic device: Results of initial feasibility trial in patients.James P Herlihy, William E Cohn, Adrian Ebner
The Journal of Vascular Access. 2025-02-10 - 1 citationsNovel Image-Guided Percutaneous Lung Tissue Excision Device With Integrated Sealing of Blood Vessels and Airways: An In Vivo Preclinical Study.Jorge E Salazar, Richard Fischel, Kenneth M Bueche, Kian Samra, Laura Gonzalez
Innovations. 2024-03-19 - Consideration of Physical Events That Result in a Palpable Arterial Pulse.William E Cohn, Trenton Gluck, O H Frazier
ASAIO Journal. 2024-03-01
Press Mentions
- ‘Incredibly Rewarding’: FDA Expands Total Artificial Heart Study After Early SuccessDecember 18th, 2024
- BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFSDecember 18th, 2024
- Heart Disease and the Quest for the Perfect Artificial HeartSeptember 4th, 2024
- Join now to see all
Industry Relationships
- Vice President, Medical Devices, Johnson&JohnsonExecutive Director of the JNJ Center for Device Innovation2016 - Present
- Board of Directors, Cardiovascular Systems Inc.2015 - Present
- Founder, BOD, TVA Medical2010 - Present
- Proctor, Consultant, Mardil2006 - 2015
- Founder, BOD, SentreHEART2005 - 2014
- Proctor, Consultant, Genzyme Surgical1997 - 2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: